Trial Profile
Examinations for immune-biological mechanism of anti-atherosclerotic effects of omega 3 lipid formula, Lotriga, focusing on commensal microbe and serum auto-antibodies.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Apr 2018
Price :
$35
*
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Hypertriglyceridaemia; Ischaemic heart disorders
- Focus Therapeutic Use
- Acronyms LR3 Trial
- 23 Apr 2018 New trial record